<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00768703</url>
  </required_header>
  <id_info>
    <org_study_id>10-01765</org_study_id>
    <secondary_id>TO CDH</secondary_id>
    <nct_id>NCT00768703</nct_id>
  </id_info>
  <brief_title>Percutaneous Endoscopic Tracheal Plug/Unplug for CDH</brief_title>
  <official_title>Percutaneous Endoscopic Tracheal Plug/Unplug for Congenital Diaphragmatic Hernia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, San Francisco</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Congenital diaphragmatic hernia is an anatomically simple birth defect in which contents of
      the fetal abdomen migrate into the chest due to incomplete formation of the diaphragm.
      Herniation of viscera into the chest prevents the fetal lungs from developing and growing to
      normal size. In the most severe cases, there is significant morbidity and mortality at birth.
      For these fetuses, fetal intervention may improve outcomes by enabling the lungs to grow
      enough in utero that they are capable of sustaining life after birth. This unblinded,
      non-randomized trial will assess the safety and efficacy of the use of the Goldvalve balloon
      and MiniTorquer microcatheter to perform percutaneous temporary tracheal occlusion to treat
      severe CDH in utero. The primary outcome variable will be fetal lung growth due to successful
      'plugging/unplugging' of the trachea, as determined by serial lung-head ratio (LHR)
      measurements. Secondary outcome variables include maternal, fetal and neonatal variables,
      specifically neonatal survival at 90 days of life. For infants who survive beyond 90 days
      post-delivery, their families will be offered follow-up (up to 2 years of age and possibly
      beyond) in the Long-term Infant-to-Adult Follow-up Evaluation (LIFE) Clinic at UCSF.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>October 2008</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Fetal lung growth due to successful fetal tracheal occlusion/unocclusion, as determined by serial LHR measurements</measure>
    <time_frame>Between 26 and 34 weeks gestation</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Neonatal survival at 90 days of life.</measure>
    <time_frame>90 days post-delivery</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Severe Congenital Diaphragmatic Hernia</condition>
  <arm_group>
    <arm_group_label>Treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Percutaneous endoscopic fetal tracheal 'plug/unplug' using the Goldvalve balloon</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Percutaneous endoscopic fetal tracheal occlusion/unocclusion</intervention_name>
    <description>Between 26-28 wks' gestation, percutaneous endoscopic placement of the tracheal balloon. Between 32-34 wks' gestation, percutaneous endoscopic removal of the balloon.</description>
    <arm_group_label>Treatment</arm_group_label>
    <other_name>Goldvalve Balloon and MiniTorquer Delivery Microcatheter</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        General subject population: Pregnant women in the second trimester, at least 18 years of
        age, and of any and all ethnic backgrounds.

        Inclusion Criteria:

          -  Confirmed diagnosis of CDH

          -  Normal fetal echocardiogram

          -  Normal karyotype

          -  Fetal liver herniated into the left hemithorax

          -  Lung-head ratio (LHR) is 1.0 or less, calculated between 24-26 weeks' gestation

          -  Fetus is between 26 and 28 weeks' gestation

          -  Singleton pregnancy

          -  Mother meets psychosocial criteria

          -  Pre-authorization from third-party payor for fetal intervention, or ability to
             self-pay.

        Exclusion Criteria:

          -  Failure to meet all inclusion criteria

          -  Other congenital anomalies detected on ultrasound

          -  Contraindication to abdominal surgery or general anesthesia

          -  Allergy to latex

          -  Preterm labor, preeclampsia, or uterine anomaly (e.g., large fibroid tumor)

          -  Family unable or refuses to stay in San Francisco for duration of the tracheal
             occlusion period and for the duration of the pregnancy as medically necessary.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hanmin Lee, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, San Francisco Fetal Treatment Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of California, San Francisco Fetal Treatment Center</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://fetus.ucsfmedicalcenter.org/</url>
    <description>UCSF Fetal Treatment Center</description>
  </link>
  <reference>
    <citation>Jani JC, Nicolaides KH, Gratacós E, Vandecruys H, Deprest JA; FETO Task Group. Fetal lung-to-head ratio in the prediction of survival in severe left-sided diaphragmatic hernia treated by fetal endoscopic tracheal occlusion (FETO). Am J Obstet Gynecol. 2006 Dec;195(6):1646-50. Epub 2006 Jun 12.</citation>
    <PMID>16769018</PMID>
  </reference>
  <reference>
    <citation>Doné E, Gucciardo L, Van Mieghem T, Jani J, Cannie M, Van Schoubroeck D, Devlieger R, Catte LD, Klaritsch P, Mayer S, Beck V, Debeer A, Gratacos E, Nicolaides K, Deprest J. Prenatal diagnosis, prediction of outcome and in utero therapy of isolated congenital diaphragmatic hernia. Prenat Diagn. 2008 Jul;28(7):581-91. doi: 10.1002/pd.2033. Review.</citation>
    <PMID>18634116</PMID>
  </reference>
  <reference>
    <citation>Cortes RA, Keller RL, Townsend T, Harrison MR, Farmer DL, Lee H, Piecuch RE, Leonard CH, Hetherton M, Bisgaard R, Nobuhara KK. Survival of severe congenital diaphragmatic hernia has morbid consequences. J Pediatr Surg. 2005 Jan;40(1):36-45; discussion 45-6.</citation>
    <PMID>15868556</PMID>
  </reference>
  <reference>
    <citation>Keller RL, Hawgood S, Neuhaus JM, Farmer DL, Lee H, Albanese CT, Harrison MR, Kitterman JA. Infant pulmonary function in a randomized trial of fetal tracheal occlusion for severe congenital diaphragmatic hernia. Pediatr Res. 2004 Nov;56(5):818-25. Epub 2004 Aug 19.</citation>
    <PMID>15319458</PMID>
  </reference>
  <reference>
    <citation>Harrison MR, Keller RL, Hawgood SB, Kitterman JA, Sandberg PL, Farmer DL, Lee H, Filly RA, Farrell JA, Albanese CT. A randomized trial of fetal endoscopic tracheal occlusion for severe fetal congenital diaphragmatic hernia. N Engl J Med. 2003 Nov 13;349(20):1916-24.</citation>
    <PMID>14614166</PMID>
  </reference>
  <reference>
    <citation>Harrison MR, Albanese CT, Hawgood SB, Farmer DL, Farrell JA, Sandberg PL, Filly RA. Fetoscopic temporary tracheal occlusion by means of detachable balloon for congenital diaphragmatic hernia. Am J Obstet Gynecol. 2001 Sep;185(3):730-3.</citation>
    <PMID>11568805</PMID>
  </reference>
  <reference>
    <citation>Ruano R, Ali RA, Patel P, Cass D, Olutoye O, Belfort MA. Fetal endoscopic tracheal occlusion for congenital diaphragmatic hernia: indications, outcomes, and future directions. Obstet Gynecol Surv. 2014 Mar;69(3):147-58. doi: 10.1097/OGX.0000000000000045. Review.</citation>
    <PMID>25102346</PMID>
  </reference>
  <reference>
    <citation>Doné E, Gratacos E, Nicolaides KH, Allegaert K, Valencia C, Castañon M, Martinez JM, Jani J, Van Mieghem T, Greenough A, Gomez O, Lewi P, Deprest J. Predictors of neonatal morbidity in fetuses with severe isolated congenital diaphragmatic hernia undergoing fetoscopic tracheal occlusion. Ultrasound Obstet Gynecol. 2013 Jul;42(1):77-83. doi: 10.1002/uog.12445.</citation>
    <PMID>23444265</PMID>
  </reference>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 6, 2008</study_first_submitted>
  <study_first_submitted_qc>October 6, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 8, 2008</study_first_posted>
  <last_update_submitted>November 1, 2016</last_update_submitted>
  <last_update_submitted_qc>November 1, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 3, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, San Francisco</investigator_affiliation>
    <investigator_full_name>Hanmin Lee</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Congenital diaphragmatic hernia</keyword>
  <keyword>lung-head ratio</keyword>
  <keyword>percutaneous tracheal occlusion</keyword>
  <keyword>fetal intervention</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hernia</mesh_term>
    <mesh_term>Hernia, Diaphragmatic</mesh_term>
    <mesh_term>Hernias, Diaphragmatic, Congenital</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

